FUND MANAGER'S PROFILE
John Hall is an investment analyst in the U.S. Equity Division, working with the health care team on the analysis of drug pipelines and existing therapeutic agents. John is a vice president of T. Rowe Price Group, Inc. He is also a vice president and an Investment Advisory Committee member of the Heath Sciences and Small-Cap Stock Funds.
The Three Drivers of Innovation in Biotech Stocks
John Hall, 2021/09/27 23:00:00.000